Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Autem Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Autem Therapeutics

Autem Therapeutics

Autem Therapeutics: Providing non-invasive, non-toxic oncology treatments with bioelectric technology.

HQ
Hanover, NH, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize cancer care, Autem Therapeutics focuses on providing non-invasive and non-toxic oncology treatments through innovative bioelectric technology. The company aims to balance the energy cycles of cancer cells, which are often desynchronized from their healthy neighbors, leading to more effective and less harmful cancer treatment options. Their market focus includes patients seeking alternative and less invasive cancer therapies.

Autem Therapeutics has garnered attention for its patent-protected approach to oncology treatment. The company is supported by a team of experts in bioelectric technology and oncology. Notable achievements include significant advancements in non-toxic cancer therapies that have the potential to improve patient outcomes and quality of life. The overall impact of Autem Therapeutics lies in its commitment to transforming cancer care by reducing the reliance on traditional, often harmful, treatment methods.

Autem Therapeutics - Similar Companies

Palm Therapeutics logo

Palm Therapeutics

Auron Therapeutics logo

Auron Therapeutics

aurontx.com

Avetabiomics logo

Avetabiomics

avetabiomics.com

Window Therapeutics logo

Window Therapeutics

windowtx.com

Dialectic Therapeutics logo

Dialectic Therapeutics

dtsciences.com

Alterome Therapeutics logo

Alterome Therapeutics

alterome.com

Bakx Therapeutics logo

Bakx Therapeutics

bakxtx.com

Parthenon Therapeutics logo

Parthenon Therapeutics

parthenontx.com

NeoTherma Oncology logo

NeoTherma Oncology

OncoPrecision logo

OncoPrecision

oncoprecision.bio

Ostentus Therapeutics logo

Ostentus Therapeutics

Telo Therapeutics logo

Telo Therapeutics

Werewolf Therapeutics logo

Werewolf Therapeutics

werewolftx.com

Eigen Therapeutics logo

Eigen Therapeutics

eigentx.com

LifeBridge Innovations logo

LifeBridge Innovations

Autem Therapeutics - Quick Facts

Who are Autem Therapeutics' competitors?

Companies similar to Autem Therapeutics include Palm Therapeutics, Auron Therapeutics, Avetabiomics and Window Therapeutics.

When was Autem Therapeutics founded?

Autem Therapeutics was founded in 2019.

Where is Autem Therapeutics' headquarters located?

Autem Therapeutics' headquarters is located in Hanover, NH, US.

When was Autem Therapeutics' last funding round?

Autem Therapeutics' most recent funding round was for $10M (USD) in June 2022.

How much has Autem Therapeutics raised to-date?

As of Jun 6, 2022, Autem Therapeutics has raised a total of $10M (USD).

How many employees does Autem Therapeutics have?

Autem Therapeutics has 35 employees as of Feb 4, 2024.

Autem Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Oncology Treatments
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified